Department of Health and Human Services, Food and Drug Administration
Studies Addressing Rare Neurodegenerative Diseases including ALS
Who can apply
- Nonprofits with 501(c)(3) status
- Private colleges and universities
- Special district governments
- Independent school districts
- Public and tribal housing authorities
- Unrestricted
- Nonprofits without 501(c)(3) status
- State governments
- City or township governments
- Small businesses
- For-profit organizations (not small businesses)
- County governments
- Federally recognized tribal governments
- Public and state-controlled colleges
- Tribal organizations
About this grant
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.
Program history
Topics
GrantCalendar is not affiliated with Department of Health and Human Services. Details can change, so confirm everything on the official listing before you apply. Spotted a mistake? Tell us.
Similar open grants
- Closes Jan 29, 2027
- Closes Sep 4, 2028
- Closes Jan 11, 2028
- Closes Apr 1, 2027
- Closes May 12, 2028
Get new grants every Monday
One short email with new grants and deadlines coming up in the next two weeks. Unsubscribe in one click.